Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT05337371 |
Other study ID # |
Cardiac Arrest ECG |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
June 1, 2022 |
Est. completion date |
May 1, 2023 |
Study information
Verified date |
April 2022 |
Source |
Charite University, Berlin, Germany |
Contact |
Tharusan Thevathasan, MD |
Phone |
+4915774407864 |
Email |
tharusan.thevathasan[@]charite.de |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The primary aim is to conduct a prospective observational cohort study to analyze the
incidence of serious arrhythmic events that occur within 14 days after hospital discharge in
patients who had been hospitalized for cardiac arrest caused by acute myocardial infarction.
Cardiac arrythmias following hospital dischagre will be detected with Philips ePatch® 2.0 for
14 days.
Description:
Approximately 60,000 patients suffer from out-of-hospital cardiac arrest in Germany every
year. Areas of myocardial ischemia may induce cardiac arrythmias, such as atrial
fibrillation, ventricular tachycardia or ventricular fibrillation, which are known arrhythmic
complications following cardiac arrest. Additionally, an imbalance in electrolytes as well as
an increased use of inotropic or vasoactive medication as part of post-resuscitation care in
the intensive care unit (ICU) may further increase the risk of cardiac arrythmias. 80% of
cardiac arrythmias occur within 24 hours after cardiac arrest in the ICU. Patients with
cardiac arrythmias following cardiac arrest have an increased mortality risk. Therefore,
patients with cardiac arrest are monitored closely with telemetric monitors in the hospital,
revascularized early and treated with beta-blockers, statins and
renin-angiotensin-aldosterone antagonists to enhance myocardial remodeling and to decrease
the rate of cardiac arrythmias. As soon as the patients are discharged from the hospital, no
telemetric ECG monitoring can be provided. Therefore, the incidence of early cardiac
arrythmias, which occur within 14 days after hospital discharge after treatment for cardiac
arrest, remains unclear.
We plan to include 100 adult patients (≥18 years and ≤80 years) who survived cardiac arrest
caused by acute myocardial infarction within the past 10 days. Patients with a
left-ventricular ejection fraction between 36 to 50% and with sinus rhythm at the time of
hospital discharge will be enrolled in this study. Patients who are suitable for implantable
cardioverter-defibrillators (ICD) or pacemakers, with known paroxysmal or persistent atrial
fibrillation, known inability to comply with follow-up or known pregnancy will not be
enrolled.
Primary aim: The primary aim is to conduct a prospective observational cohort study to
analyze the incidence of serious arrhythmic events that occur within 14 days after hospital
discharge in patients who had been hospitalized for cardiac arrest caused by acute myocardial
infarction. Cardiac arrythmias following hospital dischagre will be detected with Philips
ePatch® 2.0 for 14 days.
Secondary aims: The secondary aim is to analzye the incidence of sinus arrest, atrial
fibrillation, higher degree AV-block, ventricular tachycardia or fibrillation, all-cause
mortality, cardiovascular mortality, stroke, systemic arterial thromboembolism and unplanned
hospitalizations for decompensated heart failure within 14 days after discharge from the
index hospital stay.